Evidence map›Paper›PMID 24260458›Full record

ArticlePloS one2013

A modular organization of the human intestinal mucosal microbiota and its association with inflammatory bowel disease.

Maomeng Tong, Xiaoxiao Li, Laura Wegener Parfrey, Bennett Roth, Andrew Ippoliti, Bo Wei, James Borneman, Dermot P B McGovern, Daniel N Frank, Ellen Li and 3 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05329571 (Microbiome Correlates of Dietary Interventions in Patients With Fibromyalgia and Their Association With Symptom Modification), which is not on this map. Cited by 89 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed, 1 pooled it
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05329571 naunknown statusnot on this mapstarted 2021, after this paper: background citation

Microbiome Correlates of Dietary Interventions in Patients With Fibromyalgia and Their Association With Symptom Modification

TypeinterventionalSponsorMcGill University Health Centre/Research Institute of the McGill University Health CentreRan2021 to 2024Enrolled50ConditionsFibromyalgia, Diet, Gluten-FreeArmsLow-FODMAP diet, Gluten-free Diet, Control group
3 · Its place in the literature

Who cites it

89 citing papers in PubMed, 1 synthesis or guideline pooled it, 176 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Frontiers in microbiology · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Inhibitory effects ofFrontiers in immunology · 2023
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Role of the gut microbiome in chronic diseases: a narrative review.European journal of clinical nutrition · 2022
    Review
  20. Article

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 1 country.

Maomeng TongDepartment of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America.
Xiaoxiao Li
Laura Wegener Parfrey
Bennett Roth
Andrew Ippoliti
Bo Wei
James Borneman
Dermot P B McGovern
Daniel N Frank
Ellen Li
Steve Horvath
Rob Knight
Jonathan Braun
University of California, Los Angeles · USCedars-Sinai Medical Center · USUniversity of Colorado Boulder · USStony Brook University · USUniversity of California, Riverside · USUniversity of Colorado Denver · US

Funding

UCLA Clinical and Translational Science InstituteUL1TR000124 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUBINETT, STEVEN M. · 2012 to 2015
$57.0M
Using polygenic scores to enhance both variant discovery, and understanding of functional consequences of genetic variation in IBD.P01DK046763 · NIDDK · CEDARS-SINAI MEDICAL CENTER · PI TARGAN, STEPHAN R. · 1992 to 2020
$31.1M
Utilizing the Phenomics of IBD to Enhance Gene DiscoveryU01DK062413 · NIDDK · CEDARS-SINAI MEDICAL CENTER · PI Dermot Patrick McGovern · 2002 to 2026
$12.2M
Identifying Microorganisms involved in Human Health and Disease ProcessesR01AI078885 · NIAID · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI BORNEMAN, JAMES · 2008 to 2011
$1.4M
THE ROLE OF GWAS IDENTIFIED VARIANTS AS PREDICTORS OF OUTCOME TO ANTI-TNFa THERAPR21DK084554 · NIDDK · CEDARS-SINAI MEDICAL CENTER · PI DUBINSKY, MARLA C · 2009 to 2010
$840k
High Performance Validation and Classification of Metagenomic Ribosomal-RNA SequeR21HG005964 · NHGRI · UNIVERSITY OF COLORADO DENVER · PI FRANK, DANIEL N · 2010 to 2011
$456k
NCATS NIH HHS UL1 TR000124NCATS NIH HHS UL1TR000124NHGRI NIH HHS HG005964NHGRI NIH HHS R21 HG005964NIAID NIH HHS AI078885NIAID NIH HHS R01 AI078885NIDDK NIH HHS DK062413NIDDK NIH HHS DK084554NIDDK NIH HHS DK46763NIDDK NIH HHS P01 DK046763NIDDK NIH HHS P01DK046763NIDDK NIH HHS R21 DK084554NIDDK NIH HHS U01 DK062413
6 · The paper itself

Abstract

Abnormalities of the intestinal microbiota are implicated in the pathogenesis of Crohn's disease (CD) and ulcerative colitis (UC), two spectra of inflammatory bowel disease (IBD). However, the high complexity and low inter-individual overlap of intestinal microbial composition are formidable barriers to identifying microbial taxa representing this dysbiosis. These difficulties might be overcome by an ecologic analytic strategy to identify modules of interacting bacteria (rather than individual bacteria) as quantitative reproducible features of microbial composition in normal and IBD mucosa. We sequenced 16S ribosomal RNA genes from 179 endoscopic lavage samples from different intestinal regions in 64 subjects (32 controls, 16 CD and 16 UC patients in clinical remission). CD and UC patients showed a reduction in phylogenetic diversity and shifts in microbial composition, comparable to previous studies using conventional mucosal biopsies. Analysis of weighted co-occurrence network revealed 5 microbial modules. These modules were unprecedented, as they were detectable in all individuals, and their composition and abundance was recapitulated in an independent, biopsy-based mucosal dataset 2 modules were associated with healthy, CD, or UC disease states. Imputed metagenome analysis indicated that these modules displayed distinct metabolic functionality, specifically the enrichment of oxidative response and glycan metabolism pathways relevant to host-pathogen interaction in the disease-associated modules. The highly preserved microbial modules accurately classified IBD status of individual patients during disease quiescence, suggesting that microbial dysbiosis in IBD may be an underlying disorder independent of disease activity. Microbial modules thus provide an integrative view of microbial ecology relevant to IBD.

Indexed as

MicrobiotaCluster AnalysisCohort StudiesHumansInflammatory Bowel DiseasesIntestinal MucosaMetagenomePhenotypeRNA, Ribosomal, 16SRNA, Ribosomal, 16S

Identifiers

PMID24260458
PMCPMC3834335
OpenAlexW1979672417

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.